A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
Completed · Phase 2 · Has a placebo group
Conditions studied: Carcinoma, Non-Small-Cell Lung
In brief
This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous treatment with a platinum-based regimen
Key facts
- Study ID
- NCT00265317
- Run by
- Pfizer
- People needed
- 162
- Starts
- 2006-06-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2013-02-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with locally advanced/metastatic non-small cell lung cancer
- Prior treatment with no more than 2 chemotherapy regimens including a platinum-based regimen
You may not qualify if…
- Prior treatment with any receptor tyrosine kinase inhibitors, Vascular endothelial growth factor (VEGF) inhibitors or other angiogenic inhibitors
- History of or known brain metastases
Where it is running
- Pfizer Investigational Site — Birmingham, Alabama, United States
- Pfizer Investigational Site — Birmingham, Alabama, United States
- Pfizer Investigational Site — Mobile, Alabama, United States
- Pfizer Investigational Site — Antioch, California, United States
- Pfizer Investigational Site — Palm Springs, California, United States
- Pfizer Investigational Site — Pleasant Hill, California, United States
- Pfizer Investigational Site — San Leandro, California, United States
- Pfizer Investigational Site — Chicago, Illinois, United States
- Pfizer Investigational Site — City of Saint Peters, Missouri, United States
- Pfizer Investigational Site — Creve Coeur, Missouri, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — Chapel Hill, North Carolina, United States
- Pfizer Investigational Site — Clinton, North Carolina, United States
- Pfizer Investigational Site — Goldsboro, North Carolina, United States
- Pfizer Investigational Site — Wilson, North Carolina, United States
- Pfizer Investigational Site — Cleveland, Ohio, United States
- Pfizer Investigational Site — Houston, Texas, United States
- Pfizer Investigational Site — Edmonton, Alberta, Canada
- Pfizer Investigational Site — Hamilton, Ontario, Canada
- Pfizer Investigational Site — Budapest, Hungary
- Pfizer Investigational Site — Törökbálint, Hungary
- Pfizer Investigational Site — Genova, Italy
- Pfizer Investigational Site — Monteforte Irpino, AV, Italy
- Pfizer Investigational Site — Amsterdam, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.